Consistently, these researchers successfully showed that the attenuation of STAT-1 signaling prevents NASH (but not HCC), while inhibition of STAT-3 signaling blocks HCC development (but not NASH) [74]. This evidence concerns the gene STAT3 and metabolic dysfunction-associated steatohepatitis.